Rani Therapeutics
RANI
RANI
73 hedge funds and large institutions have $31.3M invested in Rani Therapeutics in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.08% less ownership
Funds ownership: 45.92% → 42.84% (-3.1%)
48% less capital invested
Capital invested by funds: $60.5M → $31.3M (-$29.2M)
Holders
73
Holding in Top 10
1
Calls
$3.51M
Puts
$35K
Top Buyers
| 1 | +$310K | |
| 2 | +$276K | |
| 3 | +$212K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$196K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$168K |
Top Sellers
| 1 | -$3.36M | |
| 2 | -$419K | |
| 3 | -$350K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$129K |
| 5 |
VF
Virtu Financial
New York
|
-$69K |
